Friday, October 21, 2016

Resolve Extra (Reckitt Benckiser Healthcare (UK) Ltd)





1. Name Of The Medicinal Product



Effervescent Paracetamol and Caffeine Granules



Resolve Extra


2. Qualitative And Quantitative Composition



Paracetamol 1 g



Caffeine 60 mg



Sodium Hydrogen Carbonate 1408 mg



3. Pharmaceutical Form



Effervescent granules.



4. Clinical Particulars



4.1 Therapeutic Indications



Recommended for the relief of headache with gastric upset, particularly associated with over-indulgence in food or drink or both. Contains an extra strength pain relieving formula with an antacid to settle the stomach.



4.2 Posology And Method Of Administration



Oral administration.



The granules should be dissolved in a glass of water.



Adults: One sachet up to four times daily.



Do not exceed 4 sachets in 24 hours.



The Elderly: As for adults



Children: Not recommended for children under 18 years



4.3 Contraindications



Hypersensitivity to paracetamol, caffeine, sodium bicarbonate or any of the other constituents.



4.4 Special Warnings And Precautions For Use



Care is advised in the administration of paracetamol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease.



Excessive intake of tea or coffee should be avoided while taking this product.



This product contains dextrose (glucose) and patients should consult their physician if they are suffering from diabetes before using this product.



Do not exceed the stated dose.



Patients should be advised not to take other paracetamol-containing products concurrently.



If symptoms persist, consult your doctor.



Keep out of reach of children.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



The speed of absorption of paracetamol may be increased by metoclopramide or domperidone and absorption reduced by cholyestyramine. The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol with increased risk of bleeding; occasional doses have no significant effect.



4.6 Pregnancy And Lactation



Epidemiological studies in human pregnancy have shown no ill effects due to paracetamol and caffeine used in the recommended dosage, but patients should follow the advice of their doctor regarding its use. Paracetamol and caffeine are excreted in breast milk but not in a clinically significant amount. Available published data do not contraindicate breast-feeding.



4.7 Effects On Ability To Drive And Use Machines



None.



4.8 Undesirable Effects



Adverse effects of paracetamol are rare but hypersensitivity, including skin rash, may occur. There have been rare reports of blood dyscrasias including thrombocytopenia and agranulocytosis, but these were not necessarily causally related to paracetamol.



4.9 Overdose



Symptoms of paracetamol overdose in the first 24 hours are pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning, hepatic failure may progress to encephalopathy, coma and death. Acute renal failure with acute tubular necrosis may develop even in the absence of severe liver damage. Cardiac arrhythmias and pancreatitis have been reported. Liver damage is possible in adults who have taken 10g or more of paracetamol. It is considered that excess quantities of a toxic metabolite (usually adequately detoxified by glutathione when normal doses of paracetamol are ingested) become irreversibly bound to liver tissue.



Immediate medical advice should be sought in the event of an overdose, even if you feel well.



Immediate treatment is essential in the management of paracetamol overdose. Despite a lack of significant early symptoms, patients should be referred to hospital urgently for immediate medical attention and any patient who has ingested around 7.5g or more of paracetamol in the preceding 4 hours should undergo gastric lavage. Administration of oral methionine or intravenous N-acetylcysteine which may have a beneficial effect up to at least 48 hours after the overdose, may be required. General supportive measures must be available.



Overdose of caffeine may produce nervousness, restlessness, insomnia, excitement, diuresis, facial flushing, muscle twitching, GI disturbance, tachycardia or cardiac arrhythmia, “rambling” flow of thought and speech, psychomotor agitation, or periods of inexhaustibility.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Pharmacotherapeutic group: Other Analgesics and Antipyretics, Antilides, ATC code: N02BE.



The combination of paracetamol and caffeine is a well-established analgesic combination.



5.2 Pharmacokinetic Properties



Paracetamol is rapidly and almost completely absorbed from the gastro-intestinal tract. It is relatively uniformly distributed throughout most body fluids and exhibits variable protein binding. Excretion is almost exclusively renal, in the form of conjugated metabolites.



Caffeine is absorbed readily after oral administration, maximal plasma concentrations are achieved within one hour and the plasma half-life is about 3.5 hours. 65-80% of administered caffeine is excreted in the urine as 1-methyluric acid and 1-methylxanthine.



5.3 Preclinical Safety Data



There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Citric Acid (anhydrous)



Sodium Carbonate (anhydrous)



Sodium Lauryl Sulphate



Polyvinylpyrrolidone K25



Saccharin Sodium



Dextrose (anhydrous)



Lemon Durarome



Purified Water



6.2 Incompatibilities



None.



6.3 Shelf Life



60 months.



6.4 Special Precautions For Storage



None.



6.5 Nature And Contents Of Container



Polythene/foil laminate sachets in cardboard carton outers containing 1, 5, 6 or 10 sachets.



6.6 Special Precautions For Disposal And Other Handling



None.



7. Marketing Authorisation Holder



SSL International PLC. Venus, 1 Old Park Lane, Trafford Park, Manchester, M41 7HA.



8. Marketing Authorisation Number(S)



PL 17905/0081



9. Date Of First Authorisation/Renewal Of The Authorisation



13/06/06



10. Date Of Revision Of The Text





No comments:

Post a Comment